Medicine
Swissmedic grants operating licence for new production facility
Research
PSI
The new pharmaceutical laboratory for the manufacture of radiopharmaceuticals at PSI is ready for production. With its three state-of-the-art production units, novel and innovative drugs can be brought rapidly into clinical use.
A magnetic catheter against strokes
TechTransfer
ETH Zurich
ETH spin-off Nanoflex has developed a magnetically steerable catheter for quick and safe stroke treatment that no longer requires surgeons to be on site.
Chemistry boosts drug libraries
Research
EPFL
Scientists at EPFL have found a way to synthesize large numbers of macrocyclic compounds, which are needed for developing drugs against difficult disease targets.
Severe flu risk as immune cells swap with age
Research
ETH Zurich
ETH researchers found that in mice, long-lived embryonic macrophages in the lungs die upon aging and during infection and are replaced by inflammatory bone marrow-derived macrophages. This causes severe disease progression when infected with viral flu.
Making CRISPR hype more of a reality
Research
ETH Zurich
The latest CRISPR-based genome editing systems function more like molecular taxis rather than a pair of molecular scissors. This makes them much safer for patients who will soon benefit from gene therapies, as Eric Aird explains.
Opioid poisoning on the rise
Research
ETH Zurich
Researchers at ETH have shown that cases of opioid poisoning and the prescription of opioids have increased sharply in Switzerland over the past 20 years. Although the situation is not as serious as in North America, the risk should not be underestimated.
Page 7 of 34